-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … .
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to predict, prevent … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., …
-
Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer
25 Apr 2023 11:15 GMT
Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company … held leadership roles at Aegerion Pharmaceuticals, Human Genome Sciences, Genzyme, and Amgen. She began … into the clinic.”
About Rectify Pharmaceuticals, Inc. (“Rectify”)
Rectify is …
-
InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Dr. Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights
25 Jan 2023 01:47 GMT
… at Aventis (now Sanofi), Pfizer, Human Genome Sciences (now GSK) and Biogen. Dr … -Announces-the-Appointment-of-Seasoned-Pharmaceutical-Executive-Dr-Christopher-Prior-as …
-
New cell therapy model accelerates cancer treatment development
10 Feb 2025 11:00 GMT
… at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences. He earned a BSc …
-
Unlocking Extensive Growth Opportunities of Vasculitis Treatment Market by 2031 | RNL BIO Co., Ltd., GlaxoSmithKline plc
09 Jan 2025 09:28 GMT
… plc
• Novartis AG
• Troikaa Pharmaceuticals Ltd.
• Human Genome Sciences Inc.¸ Genentech Inc.
• F. Hoffmann … -La Roche Ltd.
• Anthera Pharmaceuticals‚ Inc …
-
Subcutaneous Biologics Market Global Forecasts to 2035: Leading Players & Sales Forecast for Adocia, Alteogen, Ascendis Pharma, CD Bioparticles, Creative Biolabs, Pacira Biosciences & Xeris Biopharma - ResearchAndMarkets.com
21 Jan 2025 14:30 GMT
… address these challenges, pharmaceutical companies are utilizing innovative … Approved Subcutaneous Biologics
BENLYSTA (Human Genome Sciences)
BESREMi (PharmaEssentia)
COSENTYX … -Pacific
Alteogen
Foresee Pharmaceuticals
SUBCUTANEOUS FORMULATION TECHNOLOGIES: …
-
Subcutaneous Biologics Market, Industry Trends And Global Forecasts To 2035: Subcutaneous Biologics Set To Transform Drug Delivery And Patient Adherence
16 Jan 2025 13:02 GMT
… address these challenges, pharmaceutical companies are utilizing innovative … Approved Subcutaneous Biologics BENLYSTA (Human Genome Sciences) BESREMi (PharmaEssentia) COSENTYX … -Pacific Alteogen Foresee Pharmaceuticals SUBCUTANEOUS FORMULATION TECHNOLOGIES: …
-
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team
04 Jan 2021 21:30 GMT
… 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate … President, Finance and Treasury at Human Genome Sciences, Inc., which was acquired … University. About Checkmate Pharmaceuticals Checkmate Pharmaceuticals is a clinical stage …
-
Graphite Bio Appoints Pharmaceutical Industry Veterans to Board of Directors
21 Dec 2020 15:22 GMT
… executive officer (CEO) of Swiss pharmaceutical company Novartis, and Perry Karsen … of the world’s leading pharmaceutical companies. Mr. Jimenez joined … has held executive positions at Human Genome Sciences, Inc., a biopharmaceutical company subsequently …
About
© 1995-2025